Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Sirivichayakul, Chukiat ^a   Sabchareon, Arunee ^a   Limkittikul, Kriengsak ^a   Yoksan, Sutee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Dengue; Neutralizing antibody; Plaque reduction neutralization test

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INFECTION PREVENTION; PLAQUE REDUCTION NEUTRALIZATION TEST; PREDICTIVE VALUE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROTYPE; SYMPTOM; THAILAND; VIRUS PLAQUE;

ADOLESCENT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD; COHORT STUDIES; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; MALE; NEUTRALIZATION TESTS; THAILAND; VIRAL PLAQUE ASSAY;

EID: 84898422509     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-48     Document Type: Article

References (21)

1. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Roehrig JT, Hombach J, Barrett AD, Virol Immunol 2008 21 123 132 10.1089/vim.2008.0007 (Pubitemid 351873374)
2. Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: using PRNT50 as an endpoint for immunogenicity. Reisler RB, Danner DK, Gibbs PH, Vaccine 2010 28 2436 2441 10.1016/j.vaccine.2009.12.080 20060946
3. Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51. Eder S, Dubischar-Kastner K, Firbas C, Jelinek T, Jilma B, Kaltenboeck A, Knappik M, Kollaritsch H, Kundi M, Paulke-Korinek M, Schuller E, Klade CS, Vaccine 2011 29 2607 2612 10.1016/j.vaccine.2011.01.058 21288804
4. Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial. Feroldi E, Pancharoen C, Kosalaraksa P, Watanaveeradej V, Phirangkul K, Capeding MR, Boaz M, Gailhardou S, Bouckenooghe A, Hum Vaccin Immunother 2012 8 929 937 10.4161/hv.20071 22777096
5. A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys. Kochel TJ, Raviprakash K, Hayes CG, Watts DM, Russell KL, Gozalo AS, Phillips IA, Ewing DF, Murphy GS, Porter KR, Vaccine 2000 18 3166 3173 10.1016/S0264-410X(00) 00105-5 10856796 (Pubitemid 30345698)
6. Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children. Sabchareon A, Lang J, Chanthavanich P, Yoksan S, Forrat R, Attanath P, Sirivichayakul C, Pengsaa K, Pojjaroen-Anant C, Chambonneau L, Saluzzo JF, Bhamarapravati N, Pediatr Infect Dis J 2004 23 99 109 10.1097/01.inf.0000109289. 55856.27 14872173 (Pubitemid 38222779)
7. Dengue: guidelines for diagnosis, treatment, prevention and control. WHO, 2009 http://whqlibdoc.who.int/publications/2009/9789241547871-eng.pdf
8. Development of Sanofi Pasteur tetravalent dengue vaccine. Guy B, Saville M, Lang J, Hum Vaccin 2010 6 9 696 705 10.4161/hv.6.9.12739
9. Dengue infection in children in Ratchaburi, Thailand: a cohort study. I. Epidemiology of symptomatic acute dengue infection in children, 2006-2009. Sabchareon A, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Margolis HS, Letson GW, PLoS Negl Trop Dis 2012 6 1732 10.1371/journal.pntd.0001732 22860141
10. World Health Organization, Dengue hemorrhagic fever: diagnosis, treatment, prevention and control Geneva: WHO 1997
11. An enzyme-linked immunosorbent assay to characterize dengue infections when dengue and Japanese encephalitis co-circulate. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, Puttisri P, Hoke CH, Am J Trop Med Hyg 1989 40 418 427 2540664 (Pubitemid 19117542)
12. The use of Toxorhynchites mosquitoes to detect and propagate dengue and other arboviruses. Rosen L, Am J Trop Med Hyg 1981 30 177 183 6111230 (Pubitemid 11144876)
13. A plaque reduction test for dengue virus neutralizing antibodies. Russell PK, Nisalak A, Sukhavachana P, Vivona S, J Immunol 1967 99 285 290 6031202
14. Research on dengue during World War II. Sabin AB, Am J Trop Med Hyg 1952 1 30 50 14903434
15. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH, J Infect Dis 2004 189 990 1000 10.1086/382280 14999601 (Pubitemid 38373090)
16. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Wartel TA, Moureau A, Saville M, Bouckenooghe A, Viviani S, Tornieporth NG, Lang J, Lancet 2012 380 1559 1567 10.1016/S0140-6736(12)61428-7 22975340
17. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32). Rodrigo WW, Jin X, Blackley SD, Rose RC, Schlesinger JJ, J Virol 2006 80 10128 10138 10.1128/JVI.00792-06 17005690 (Pubitemid 44522606)
18. Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells. Moi ML, Lim CK, Chua KB, Takasaki T, Kurane I, PLoS Negl Trop Dis 2012 6 1536 10.1371/journal.pntd.0001536 22389741
19. Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infection: how alteration in assay conditions impact performance. Thomas SJ, Nisalak A, Anderson KB, Libraty DH, Kalayanarooj S, Vaughn DW, Putnak R, Gibbons RV, Jarman R, Endy TP, Am J Trop Med Hyg 2009 81 825 833 10.4269/ajtmh.2009.08-0625 19861618
20. Variation in dengue virus plaque reduction neutralization testing: systematic review and pool analysis. Rainwater-Lovett K, Rodriguez-Barraquer I, Cummings DA, Lessler J, BMC Infect Dis 2012 12 233 10.1186/1471-2334-12-233 23020074
21. Molecular evolution and epidemiology of four serotypes of dengue virus in Thailand from 1973 to 2007. Chen SP, Epidemiol Infect 2012 14 1 6